Balance Sheet Jaguar Health, Inc.

Stocks

JAGX

US47010C8626

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 02:00:00 21/07/2026 am IST			5-day change	1st Jan Change
1.265 ^USD	-2.69%		-43.78%	-96.12%

25/06	Jaguar Health, Inc., Napo Pharmaceuticals, Inc., And Woodward Specialty LLC Amend Manufacturing And Supply Agreement	CI
24/06	Jaguar Health Initiates Strategic-Alternatives Review Ahead of Crofelemer NDA Filing for Rare Intestinal Failure Program	CI

96992febe03b6.TD2cjTl0cVSb8seX1CGsKPVbq4LsvalmVfpuzC8-0H4.fW7ouWgtBxbiovO6tVfqY69qycO51M0uN55dhRpk5gsfCOzbVw0fEtPFlg

Published financial data: JAGUAR HEALTH, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	43.35L	1.2Cr	97.61L	1.17Cr	1.15Cr
Total Revenues	43.35L	1.2Cr	97.61L	1.17Cr	1.15Cr
Cost of Goods Sold, Total	23.33L	20.19L	20.37L	19.55L	37.74L
Gross Profit	20.02L	99.37L	77.24L	97.34L	77.37L
Selling General & Admin Expenses, Total	2.6Cr	2.67Cr	2.3Cr	2.4Cr	2.79Cr
R&D Expenses	1.51Cr	1.76Cr	1.86Cr	1.65Cr	2.5Cr
Other Operating Expenses, Total	4.11Cr	4.44Cr	4.16Cr	4.06Cr	5.28Cr
Operating Income	-3.91Cr	-3.44Cr	-3.39Cr	-3.08Cr	-4.51Cr
Interest Expense, Total	-84.21L	-1.27Cr	-63.82L	-2L	-67T
Net Interest Expenses	-84.21L	-1.27Cr	-63.82L	-2L	-67T
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	-27.18L	9L	-49.25L	-94.34L	-62.23L
EBT, Excl. Unusual Items	-5.02Cr	-4.62Cr	-4.52Cr	-4.05Cr	-5.14Cr
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Asset Writedown	-	-	-4L	-	-
In Process R&D Expenses	-	-	-	-	-8L
Insurance Settlements	-	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-23.87L	-21.87L	36.97L	12.45L	-17.99L
EBT, Incl. Unusual Items	-5.26Cr	-4.84Cr	-4.19Cr	-3.93Cr	-5.4Cr
Income Tax Expense	-	-	-	-	-
Earnings From Continuing Operations	-5.26Cr	-4.84Cr	-4.19Cr	-3.93Cr	-5.4Cr
Net Income to Company	-5.26Cr	-4.84Cr	-4.19Cr	-3.93Cr	-5.4Cr
Minority Interest	-	9L	6L	8L	6L
Net Income - (IS)	-5.26Cr	-4.75Cr	-4.13Cr	-3.85Cr	-5.34Cr
Preferred Dividend and Other Adjustments	-	-	-	-	1L
Net Income to Common Incl Extra Items	-5.26Cr	-4.75Cr	-4.13Cr	-3.85Cr	-5.36Cr
Net Income to Common Excl. Extra Items	-5.26Cr	-4.75Cr	-4.13Cr	-3.85Cr	-5.36Cr
Per Share Items
Net EPS - Basic	-	-	-	-	-803.95
Basic EPS - Continuing Operations	-	-	-	-	-803.95
Basic Weighted Average Shares Outstanding	-	-	-	-	66.64T
Net EPS - Diluted	-	-	-	-	-803.95
Diluted EPS - Continuing Operations	-	-	-	-	-803.95
Diluted Weighted Average Shares Outstanding	-	-	-	-	66.64T
Normalized Basic EPS	-	-	-	-	-473.6
Normalized Diluted EPS	-	-	-	-	-473.6
Supplemental Items
EBITDA	-3.74Cr	-3.24Cr	-3.19Cr	-2.89Cr	-4.32Cr
EBITA	-3.74Cr	-3.26Cr	-3.19Cr	-2.89Cr	-4.32Cr
EBIT	-3.91Cr	-3.44Cr	-3.39Cr	-3.08Cr	-4.51Cr
EBITDAR	-3.71Cr	-3.18Cr	-3.1Cr	-2.81Cr	-4.27Cr
Total Revenues (As Reported)	-	1.2Cr	-	1.17Cr	1.15Cr
Effective Tax Rate - (Ratio)	-	-	-	-	-
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	-	-	-	-	-
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	-3.14Cr	-2.79Cr	-2.77Cr	-2.46Cr	-3.16Cr
Interest on Long-Term Debt	84.21L	1.27Cr	63.82L	4L	600
Supplemental Operating Expense Items
Marketing Expenses	34.15L	35.96L	19.03L	24.07L	27.44L
Selling and Marketing Expenses	88.94L	88.37L	64.6L	76.92L	92.35L
General and Administrative Expenses	1.68Cr	1.72Cr	1.57Cr	1.55Cr	1.81Cr
Research And Development Expense From Footnotes	1.51Cr	1.76Cr	1.86Cr	1.65Cr	2.58Cr
Net Rental Expense, Total	3L	6L	9L	8L	5L
Imputed Operating Lease Interest Expense	8L	19.94L	12.45L	41.01T	6.84T
Imputed Operating Lease Depreciation	-6L	-13.65L	-4L	8L	5L
Stock-Based Comp., COGS (Total)	-	-	-	-	-
Stock-Based Comp., R&D Exp. (Total)	13.19L	12.63L	10.44L	7L	3L
Stock-Based Comp., S&M Exp. (Total)	3L	3L	2L	1L	1L
Stock-Based Comp., G&A Exp. (Total)	23.36L	17.88L	9L	8L	5L
Stock-Based Comp., Other (Total)	16T	8L	2L	9T	-
Total Stock-Based Compensation	39.9L	41.41L	22.83L	16.5L	8L

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.71Cr	54.69L	64.69L	80.02L	10L
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	1.71Cr	54.69L	64.69L	80.02L	10L
Accounts Receivable, Total	17.09L	18.79L	19.67L	15.27L	15.21L
Other Receivables	4L	6L	2L	1L	2L
Total Receivables	21.44L	24.67L	21.84L	16.47L	16.98L
Inventory	49L	70.24L	91.89L	1.03Cr	85.99L
Prepaid Expenses	43.39L	73.61L	1.01Cr	1.22Cr	22.16L
Restricted Cash	-	-	-	-	68.64L
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	2.84Cr	2.23Cr	2.8Cr	3.22Cr	2.03Cr
Gross Property Plant And Equipment	20.32L	21.01L	21.37L	19.13L	20.21L
Accumulated Depreciation	-3L	-4L	-5L	-5L	-6L
Net Property Plant And Equipment	17.34L	16.97L	16.72L	14L	14.63L
Goodwill	-	-	-	-	-
Other Intangibles, Total	2.27Cr	2.24Cr	2.01Cr	1.85Cr	1.6Cr
Other Long-Term Assets, Total	4L	10L	10.12L	13.48L	5L
Total Assets	5.33Cr	4.75Cr	5.08Cr	5.34Cr	3.83Cr
Liabilities
Accounts Payable, Total	49.29L	58.08L	49.74L	52.86L	86.86L
Accrued Expenses, Total	71.17L	81.65L	37.98L	19.11L	24.32L
Short-term Borrowings	-	-	-	1L	2L
Current Portion of Long-Term Debt	31.84L	1.59Cr	48.67L	1.19Cr	2.73Cr
Current Portion of Leases	2L	5L	3L	3L	2L
Unearned Revenue Current, Total	-	-	-	2L	2L
Other Current Liabilities	1T	-	-	-	17.34L
Total Current Liabilities	1.55Cr	3.03Cr	1.4Cr	1.97Cr	4.07Cr
Long-Term Debt	2.5Cr	1.77Cr	3.1Cr	2.35Cr	1.51Cr
Long-Term Leases	9L	7L	9L	7L	9L
Unearned Revenue Non Current	-	-	-	6L	4L
Total Liabilities	4.14Cr	4.88Cr	4.59Cr	4.44Cr	5.7Cr
Preferred Stock Redeemable	-	-	-	24.85L	24.85L
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	24.85L	24.85L
Common Stock, Total	5T	-	7T	-	1T
Additional Paid In Capital	23Cr	27Cr	31Cr	35Cr	38Cr
Retained Earnings	-22Cr	-27Cr	-31Cr	-35Cr	-40Cr
Comprehensive Income and Other	-	-7L	-7L	-5L	-8L
Total Common Equity	1.16Cr	-7L	49.61L	72.85L	-1.98Cr
Minority Interest	2L	-7L	-64T	-8L	-13.99L
Total Equity	1.19Cr	-13.56L	48.97L	89.79L	-1.87Cr
Total Liabilities And Equity	5.33Cr	4.75Cr	5.08Cr	5.34Cr	3.83Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	-	-	-	19.26T	4L
ECS Total Common Shares Outstanding	-	-	-	15.1T	2L
Book Value / Share	-	-	-	482.51	-99.2
Tangible Book Value	-1.1Cr	-2.31Cr	-1.52Cr	-1.12Cr	-3.58Cr
Tangible Book Value Per Share	-	-	-	-741.42	-179.58
Total Debt	2.94Cr	3.48Cr	3.71Cr	3.65Cr	4.36Cr
Net Debt	1.23Cr	2.94Cr	3.06Cr	2.85Cr	4.26Cr
Debt Equivalent Oper. Leases	22.56L	50.32L	70.16L	65.36L	40.88L
Minority Interest, Total (Incl. Fin. Div)	2L	-7L	-64T	-8L	-13.99L
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	12.48L	21.01L	20.57L	18.5L	20.41L
Inventories - Work In Process, Total	27.6L	35.99L	65.17L	74.07L	72.36L
Inventories - Finished Goods, Total	9L	13.24L	6L	10.88L	13.22L
Inventories - Others	-	-	-	-	-
Land - (BS)	4L	4L	4L	4L	4L
Machinery, Total	5L	5L	5L	5L	6L
Full Time Employees	52	60	49	49	47
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-5.26Cr	-4.75Cr	-4.13Cr	-3.85Cr	-5.34Cr
Depreciation & Amortization - CF	1L	5L	4L	5L	3L
Amortization of Goodwill and Intangible Assets - (CF)	17L	18L	20L	19L	19L
Depreciation & Amortization, Total	18.13L	22.92L	23.88L	23.58L	22.02L
Amortization of Deferred Charges, Total - (CF)	51.71L	1.18Cr	1.32Cr	3L	2L
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	4L	-	8L
(Income) Loss On Equity Investments - (CF)	-	-	51T	1L	2L
Stock-Based Compensation (CF)	39.9L	41.41L	22.83L	16.5L	8L
Other Operating Activities, Total	43.89L	6L	9L	76.98L	90.91L
Change In Accounts Receivable	28.23L	-2L	-88T	4L	6T
Change In Inventories	-21.18L	-21.24L	-21.65L	-11.56L	-3L
Change In Accounts Payable	2L	9L	-9L	3L	33.46L
Change in Unearned Revenues	-	-	-	7L	-2L
Change in Other Net Operating Assets	14.04L	-30.36L	-79.91L	-33.45L	1.36Cr
Cash from Operations	-3.5Cr	-3.31Cr	-3.32Cr	-2.94Cr	-2.37Cr
Capital Expenditure	-6T	-77T	-	-16T	-41T
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-15.98L	-	-2L	-
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-6T	-16.75L	-	-2L	-41T
Short Term Debt Issued, Total	-	39.75L	-	-	1Cr
Long-Term Debt Issued, Total	1.1Cr	-	-	-	34.45L
Total Debt Issued	1.1Cr	39.75L	-	-	1.34Cr
Short Term Debt Repaid, Total	-9L	-11.56L	-9L	-6L	-7L
Long-Term Debt Repaid, Total	-19.22L	-1L	-1L	-1L	-1L
Total Debt Repaid	-28.65L	-12.56L	-10L	-7L	-8L
Issuance of Common Stock	3.86Cr	2.06Cr	3.23Cr	3.21Cr	87.45L
Repurchase of Common Stock	-	-	-	-	-
Issuance of Preferred Stock	-	-	6L	-	23.77L
Other Financing Activities, Total	-28.53L	-1L	22.15L	-2L	-1L
Cash from Financing	4.39Cr	2.32Cr	3.42Cr	3.12Cr	2.37Cr
Foreign Exchange Rate Adjustments	-	16T	15T	-54T	-1L
Net Change in Cash	89.61L	-1.16Cr	10L	15.33L	-2L
Supplemental Items
Cash Interest Paid	28T	23T	35T	14T	22T
Levered Free Cash Flow	-1.78Cr	-1.65Cr	-1.72Cr	-1.95Cr	-1.46Cr
Unlevered Free Cash Flow	-1.77Cr	-2.03Cr	-2.64Cr	-1.96Cr	-1.47Cr
Change In Net Working Capital	-9L	35.43L	98.43L	41.07L	-1.05Cr
Net Debt Issued / Repaid	81.6L	27.19L	-10L	-7L	1.27Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-50.82	-42.71	-43.17	-36.99	-61.46
Return on Total Capital	-65.45	-57.59	-56.18	-44.05	-80.06
Return On Equity %	-362.07	-922.07	-2.37T	-565.74	1.11T
Return on Common Equity	-365.11	-866.42	-1.92T	-628.65	857.96
Margin Analysis
Gross Profit Margin %	46.18	83.11	79.13	83.27	67.21
SG&A Margin	599.7	223.36	236.12	205.52	242.19
EBITDA Margin %	-861.71	-271.28	-326.88	-247.51	-375.25
EBITA Margin %	-862.15	-272.79	-327.02	-247.51	-375.36
EBIT Margin %	-901.36	-287.85	-347.51	-263.76	-391.87
Income From Continuing Operations Margin %	-1.21T	-404.78	-429.27	-335.79	-469.09
Net Income Margin %	-1.21T	-396.91	-423.11	-329.3	-464.2
Net Avail. For Common Margin %	-1.21T	-396.91	-423.11	-329.3	-465.42
Normalized Net Income Margin	-723.95	-233.68	-283.43	-210.04	-274.18
Levered Free Cash Flow Margin	-410.18	-137.91	-175.75	-166.56	-126.97
Unlevered Free Cash Flow Margin	-408.06	-169.74	-270.18	-167.67	-127.93
Asset Turnover
Asset Turnover	0.09	0.24	0.2	0.22	0.25
Fixed Assets Turnover	3.6	6.97	5.79	7.61	8.04
Receivables Turnover (Average Receivables)	2.28	6.66	5.08	6.69	7.55
Inventory Turnover (Average Inventory)	0.61	0.34	0.25	0.2	0.4
Short Term Liquidity
Current Ratio	1.84	0.74	2	1.63	0.5
Quick Ratio	1.24	0.26	0.62	0.49	0.07
Operating Cash Flow to Current Liabilities	-2.26	-1.09	-2.38	-1.49	-0.58
Days Sales Outstanding (Average Receivables)	160.27	54.77	71.91	54.7	48.32
Days Outstanding Inventory (Average Inventory)	600.93	1.08T	1.45T	1.83T	916.08
Average Days Payable Outstanding	397.23	472.97	468.28	603.53	1.26T
Cash Conversion Cycle (Average Days)	363.97	659.63	1.06T	1.28T	-292.94
Long Term Solvency
Total Debt/Equity	247.74	-2.57T	757.48	406.79	-233.34
Total Debt / Total Capital	71.24	104.05	88.34	80.27	174.99
LT Debt/Equity	218.86	-1.36T	650.99	269.4	-85.48
Long-Term Debt / Total Capital	62.94	55.17	75.92	53.16	64.11
Total Liabilities / Total Assets	77.75	102.86	90.35	83.19	148.76
EBIT / Interest Expense	-4.64	-2.7	-5.31	-133.47	-673.25
EBITDA / Interest Expense	-4.4	-2.5	-4.86	-121.71	-637.07
(EBITDA - Capex) / Interest Expense	-4.4	-2.51	-4.86	-121.77	-637.69
Total Debt / EBITDA	-0.79	-1.1	-1.2	-1.3	-1.02
Net Debt / EBITDA	-0.33	-0.92	-0.99	-1.01	-1
Total Debt / (EBITDA - Capex)	-0.79	-1.09	-1.2	-1.3	-1.02
Net Debt / (EBITDA - Capex)	-0.33	-0.92	-0.99	-1.01	-1
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-53.81	175.8	-18.36	19.75	-1.52
Gross Profit, 1 Yr. Growth %	-67.83	396.35	-22.27	26.02	-20.52
EBITDA, 1 Yr. Growth %	102.37	-13.17	-1.62	-9.33	49.3
EBITA, 1 Yr. Growth %	102.17	-12.73	-2.13	-9.36	49.35
EBIT, 1 Yr. Growth %	93.57	-11.92	-1.44	-9.11	46.31
Earnings From Cont. Operations, 1 Yr. Growth %	55.58	-7.99	-13.42	-6.32	37.57
Net Income, 1 Yr. Growth %	55.58	-9.77	-12.97	-6.8	38.82
Normalized Net Income, 1 Yr. Growth %	97.04	-10.96	-0.98	-11.26	28.55
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-	-	-
Accounts Receivable, 1 Yr. Growth %	-18.54	9.95	4.68	-22.37	-0.39
Inventory, 1 Yr. Growth %	76.13	43.35	30.82	12.58	-16.88
Net Property, Plant and Equip., 1 Yr. Growth %	156.13	-2.13	-1.47	-16.27	4.5
Total Assets, 1 Yr. Growth %	24.33	-10.91	6.98	5.24	-28.27
Tangible Book Value, 1 Yr. Growth %	54.73	109.2	-34.38	-26.14	219.77
Common Equity, 1 Yr. Growth %	-32.5	-105.66	-855.1	46.85	-371.43
Cash From Operations, 1 Yr. Growth %	128.89	-5.34	0.42	-11.61	-19.39
Capital Expenditures, 1 Yr. Growth %	-14.29	1.18T	-	-	156.25
Levered Free Cash Flow, 1 Yr. Growth %	118.68	-7.27	4.04	13.49	-24.93
Unlevered Free Cash Flow, 1 Yr. Growth %	95.33	14.73	29.95	-25.68	-24.86
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-13.36	12.87	50.06	-1.12	8.59
Gross Profit, 2 Yr. CAGR %	1.09	26.37	96.42	-1.03	0.08
EBITDA, 2 Yr. CAGR %	28.67	32.56	-7.58	-5.55	16.35
EBITA, 2 Yr. CAGR %	28.6	32.83	-7.58	-5.82	16.35
EBIT, 2 Yr. CAGR %	26.81	30.57	-6.83	-5.35	15.32
Earnings From Cont. Operations, 2 Yr. CAGR %	16.83	19.64	-10.75	-9.94	13.52
Net Income, 2 Yr. CAGR %	16.83	18.47	-11.39	-9.94	13.75
Normalized Net Income, 2 Yr. CAGR %	31.72	32.44	-6.1	-6.26	6.81
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-	-	-
Accounts Receivable, 2 Yr. CAGR %	0.5	-5.36	7.28	-9.85	-12.06
Inventory, 2 Yr. CAGR %	51.71	58.9	36.94	21.36	-3.26
Net Property, Plant and Equip., 2 Yr. CAGR %	56.28	58.32	-1.8	-9.17	-6.46
Total Assets, 2 Yr. CAGR %	20.95	5.24	-2.38	6.11	-13.11
Tangible Book Value, 2 Yr. CAGR %	-19.56	79.92	17.16	-30.38	53.69
Common Equity, 2 Yr. CAGR %	13.83	-80.46	-34.63	232.99	99.65
Cash From Operations, 2 Yr. CAGR %	30.75	47.2	-2.5	-5.79	-15.59
Capital Expenditures, 2 Yr. CAGR %	-	231.66	-	-54.42	-
Levered Free Cash Flow, 2 Yr. CAGR %	25.46	42.4	-1.78	8.67	-7.7
Unlevered Free Cash Flow, 2 Yr. CAGR %	17.23	49.7	22.1	-1.73	-25.27
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-0.62	27.45	1.32	39.19	-1.26
Gross Profit, 3 Yr. CAGR %	-17.02	71.82	7.47	69.41	-8
EBITDA, 3 Yr. CAGR %	15.42	12.86	20.01	-8.17	10.02
EBITA, 3 Yr. CAGR %	16.03	13.01	19.97	-8.18	9.83
EBIT, 3 Yr. CAGR %	15.12	12.3	18.89	-7.59	9.44
Earnings From Cont. Operations, 3 Yr. CAGR %	17.84	7.89	7.41	-9.3	3.72
Net Income, 3 Yr. CAGR %	17.84	7.18	6.9	-9.88	4.04
Normalized Net Income, 3 Yr. CAGR %	21.67	15.6	20.21	-7.85	4.15
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-	-
Accounts Receivable, 3 Yr. CAGR %	19.73	3.56	-2.13	-3.68	-6.8
Inventory, 3 Yr. CAGR %	13.6	48.87	48.93	28.29	6.98
Net Property, Plant and Equip., 3 Yr. CAGR %	31.61	33.7	35.17	-6.88	-4.83
Total Assets, 3 Yr. CAGR %	9.08	9.23	5.82	0.1	-6.87
Tangible Book Value, 3 Yr. CAGR %	-25.15	10.62	28.54	0.46	15.73
Common Equity, 3 Yr. CAGR %	29.2	-58.15	-33.93	-14.39	211.06
Cash From Operations, 3 Yr. CAGR %	15.44	17.4	29.58	-5.64	-10.56
Capital Expenditures, 3 Yr. CAGR %	-2.77	-	-	38.67	-18.95
Levered Free Cash Flow, 3 Yr. CAGR %	6.3	13.43	28.26	3.07	-3.94
Unlevered Free Cash Flow, 3 Yr. CAGR %	7.2	16.39	42.8	3.48	-10.14
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	98.26	22.35	17.19	15.14	4.17
Gross Profit, 5 Yr. CAGR %	-22.41	65.99	17.12	37.8	4.45
EBITDA, 5 Yr. CAGR %	22.68	23.85	5.6	5.1	18.53
EBITA, 5 Yr. CAGR %	22.62	23.06	5.93	5.06	18.51
EBIT, 5 Yr. CAGR %	23.72	24.37	5.78	4.88	17.45
Earnings From Cont. Operations, 5 Yr. CAGR %	28.98	17.11	5.44	0.37	9.82
Net Income, 5 Yr. CAGR %	28.98	16.65	5.14	-0.02	9.59
Normalized Net Income, 5 Yr. CAGR %	28.16	30.1	9.69	6.3	14.66
Accounts Receivable, 5 Yr. CAGR %	221.66	32.07	14.59	-2.03	-6.23
Inventory, 5 Yr. CAGR %	64.02	27.65	22.42	37.19	25.32
Net Property, Plant and Equip., 5 Yr. CAGR %	14.37	6.79	17.06	14.54	16.66
Total Assets, 5 Yr. CAGR %	71.76	1.69	4.34	7.97	-2.21
Tangible Book Value, 5 Yr. CAGR %	35.09	1.59	-10.46	-8.09	38.07
Common Equity, 5 Yr. CAGR %	36.46	-47.99	-1.62	-4.06	2.83
Cash From Operations, 5 Yr. CAGR %	19.39	27.5	7.9	7.51	9.17
Capital Expenditures, 5 Yr. CAGR %	-43.5	-	-	-	42.41
Levered Free Cash Flow, 5 Yr. CAGR %	8.1	113.07	2.99	11.5	12.44
Unlevered Free Cash Flow, 5 Yr. CAGR %	8.18	107.22	12.93	8.77	10.21